Clonazepam Recall 2024 Lexus. Ndoi) (“endo”), announced today that one of its operating subsidiaries, endo usa, inc., is voluntarily recalling one lot of clonazepam orally. 19, 2024, endo pharmaceuticals, the parent company of par pharmaceuticals, notified the fda of an expansion of its voluntary recall of clonazepam orally disintegrating tablets.

Ndoi) (endo), announced today that one of its operating subsidiaries, endo usa, inc., is voluntarily recalling one lot of. Food and drug administration (fda) announced a recall of some lots of orally disintegrating clonazepam tablets (the generic form of klonopin), due to package.